Alvogen, Inc. is recalling approximately 7,056 bottles of Nitrofurantoin Monohydrate/Macrocrystals and Macrobid (nitrofurantoin monohydrate/macrocrystals) capsules, which are used to treat urinary tract infections. These medications were found to fail dissolution specifications, meaning the drug may not dissolve properly in the body. If the medication does not dissolve as intended, it may not be absorbed correctly, potentially reducing the effectiveness of the antibiotic treatment. Consumers who have these medications should contact their healthcare provider or pharmacist for guidance and to obtain a replacement prescription.
The drug failed to meet dissolution standards, which can lead to lower-than-intended levels of the medication in the bloodstream, potentially resulting in treatment failure for urinary tract infections.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.